-92%

est. 2Y upside i

HealthcareAI & MLSeed

AI-native psychiatry, built for scale and covered by insurance

Rank

#3252

Sector

Digital Health, AI, Mental Health

Est. Liquidity

~5Y

Data Quality

Data: Medium

Legion Health presents a moderate upside opportunity for a job seeker, but with a higher risk profile due to its early stage and competitive landscape.

Last updated: March 10, 2026

Bull (15%)+300%

Legion Health's proprietary AI and specialist psychiatry focus gain significant traction, capturing substantial market share from less specialized competitors. Revenue scales rapidly to over $50M by 2028, justifying a $160M+ valuation (4x current assumed valuation) in a Series C or acquisition, providing strong returns for early equity holders.

Base (30%)+75%

The company achieves steady growth, expanding its network and AI capabilities, but faces ongoing competition. Revenue reaches approximately $15M-$20M by 2028, leading to a Series B or C round at a $70M valuation (1.75x current assumed valuation), offering a moderate return on equity.

Bear (55%)-85%

Aggressive moves by well-funded incumbents or new entrants, coupled with slower-than-expected revenue growth and high burn, lead to a challenging funding environment. A down round or acquisition at a significantly reduced valuation (e.g., $6M, below total funding) wipes out most common stock value due to liquidation preferences.

Est. time to liquidity~5.0 years

Preference Stack Risk

high

Investors hold $10M in liquidation preferences ahead of common stock holders. In an exit at or below $10M, common stock holders would receive little to nothing.

Dilution Risk

high

As a seed-stage company with low revenue, Legion Health will likely require several more funding rounds, which will dilute existing equity holders.

Secondary Liquidity

none

No active secondary market or tender offers are expected for a company at this early stage.

Questions to Ask at the Interview

Strategic questions based on Legion Health's data — designed to show you've done your homework.

  • 1

    Given the significant funding raised by competitors like Talkiatry, how does Legion Health plan to sustain its growth and effectively differentiate its AI-driven specialist psychiatry model in this increasingly crowded market?

  • 2

    With current estimated revenue around $1.7M, what are the specific key performance indicators and growth targets for the next 12-24 months that will demonstrate scalability and position the company for successful future funding rounds?

  • 3

    Considering the $10M in total funding and the early stage of the company, what is the company's strategy for managing potential future dilution for employees, and what is the anticipated timeline for a liquidity event for common stock holders?

Community

Valuation Sentiment

Our model estimates -92% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.